Skip to main content

Table 2 Demographic characteristics, treatment, and visual outcomes of patients with birdshot chorioretinopathy

From: Visual response and anatomical changes on sequential spectral-domain optical coherence tomography in birdshot chorioretinopathy treated with local corticosteroid therapy

Patient Onset presentation Prior treatment VA initial VA final Disease course OD Disease course OS Family history HLA A29 Treatment
1 54 yo None 20/50 OD 20/50 OD VC, ERM, RD, CME, PCL VC, ERM, CME, PCL, CNVb No Positive Focal laser OS, pneumatic retinopexy OD, IVK × 711 OD, IVK × 9 OS
54 yo 20/30 OS 20/30 OS
2 48 yo None 20/30 OD 20/50 OD ERM, CME, PCL, glaucomac ERM, PCL Yes Positive Subtenon triamcinolone acetate OD, DC secondary to glaucoma
48 yo 20/20 OS 20/30 OS
3 34 yo Systemic immuno-suppressantsa 20/70 OD 20/40 OD ERM, CME, PCL ERM, CME, PCL Yes Positive IVK × 4 OD, IVK × 5 OS
40 yo 20/60 OS 20/200 OS
4 26 yo None 20/40 OD 20/40 OD VC, PVD, PCL VC, PVD, CME, PCL No Positive IVK × 1 OD, IVK × 2 OS
54 yo 20/200 OS 20/70 OS
  1. PCL pale choroidal lesions, ERM epiretinal membrane, RD retinal detachement, CME cystoid macular edema, CNV choroidal neovascularization, VC vitreous cell, C/D cup to disk, IVK intravitreal triamcinolone acetate, PRP pan-retinal photocoagulation, N/A not applicable, PVD posterior vitreous detachment
  2. aCyclosporine, extrafoveal, non-compliant to glaucoma medication